O

Olema Oncology

Clinical-stage biopharma targeting ER-positive breast cancer

Executive Assistant - Supporting Chief Financial Officer

Executive SupportConfirmed live in the last 24 hours
Full-timeSan Francisco, CA, USA

About the Job

Requirements

  • A bachelor's degree is strongly preferred.
  • Advanced proficiency with Microsoft Office, including Outlook, Teams, Excel, and PowerPoint, as well as Zoom, Concur, and other business systems.
  • At least 5 years of experience supporting C-suite executives and senior leaders, including Vice Presidents and/or Senior Directors.
  • Experience working in the biotechnology or pharmaceutical industry is required.
  • Experience supporting investor relations activities is required.
  • Demonstrated success managing multiple priorities in a fast-paced environment with changing business needs.
  • Exceptional organizational skills, strong attention to detail, and the ability to manage complex calendars, meetings, travel, and logistics for multiple executives.
  • Excellent written and verbal communication skills and strong interpersonal skills to interface with key stakeholders.
  • Strong judgment, problem-solving skills, and the ability to anticipate needs and proactively resolve issues.
  • Ability to handle confidential information with the highest level of discretion.
  • A proactive and resourceful approach, with a strong sense of ownership and accountability.
  • Flexibility and adaptability in managing multiple priorities and shifting business needs.
  • Ability to build collaborative relationships across functions and organizational levels.
  • Ability to remain calm, composed, and solutions-oriented under pressure.

Responsibilities

  • Provide day-to-day administrative support to the Chief Financial Officer and approximately 4–6 senior leaders.
  • Manage complex calendars for multiple executives, balance competing priorities, and coordinate meetings across internal and external stakeholders, including investors and other key external parties.
  • Coordinate meetings and events, including scheduling, conference room management, agendas, meeting materials, presentations, catering, and follow-up as needed.
  • Coordinate external investor and scientific events, including venues, travel, accommodation, meals, and other activities as necessary.
  • Arrange complex domestic and international travel, prepare detailed itineraries, and process expense reports through Concur.
  • Prepare executives for internal and external meetings by coordinating materials, presentations, and supporting documentation.
  • Serve as a primary point of contact for internal and external stakeholders, including executive team members, Board members, investors, consultants, business partners, and vendors.
  • Build partnerships with cross-functional teams to coordinate schedules, meetings, and other business activities.
  • Coordinate executive schedules with the Executive Assistant team, share best practices, and provide coverage as needed.
  • Support leadership meetings, team meetings, offsites, executive visits, candidate interviews, and other special events.
  • Process purchase orders, onboard vendors, and manage invoices and other administrative activities.
  • Help maintain an organized, productive, and welcoming office environment, including conference room coordination and office support as needed.
  • Handle confidential and sensitive information with professionalism, discretion, and sound judgment.
  • Adapt support to changing business priorities and the evolving needs of the CFO's organization.

About the Company

Olema Oncology

Clinical-stage biopharma targeting ER-positive breast cancer

Olema Oncology develops targeted therapies for women’s cancers, with a focus on ER-positive, HER2-negative breast cancer. Its lead drug, palazestrant (OP-1250), blocks and degrades the estrogen receptor (CERAN/SERD) to slow tumor growth, and a second program targets epigenetics with a KAT6 inhibitor in preclinical stages. The company is conducting a Phase 3 trial of palazestrant in combination with CDK4/6 inhibitors and has a collaboration with Novartis to test palazestrant with ribociclib and everolimus. Its goal is to bring palazestrant to market and advance the KAT6 program to clinical testing, expanding options for women with breast cancer.

Company size
51-200
Company stage
IPO
Headquarters
San Francisco, CA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Olema Oncology

See more jobs